4.5 Article

Brain Disposition and Catalepsy After Intranasal Delivery of Loxapine: Role of Metabolism in PK/PD of Intranasal CNS Drugs

Related references

Note: Only part of the references are listed.
Review Pharmacology & Pharmacy

Intranasal delivery of biologics to the central nervous system

Jeffrey J. Lochhead et al.

ADVANCED DRUG DELIVERY REVIEWS (2012)

Review Biochemistry & Molecular Biology

Regioselective biotransformation of CNS drugs and its clinical impact on adverse drug reactions

Yin Cheong Wong et al.

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2012)

Article Pharmacology & Pharmacy

Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route

Sonal Patel et al.

JOURNAL OF DRUG TARGETING (2011)

Review Neurosciences

Diencephalic and brainstem mechanisms in migraine

Simon Akerman et al.

NATURE REVIEWS NEUROSCIENCE (2011)

Article Pharmacology & Pharmacy

Behavioral Indices in Antipsychotic Drug Discovery

Roger D. Porsolt et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)

Article Medicine, Research & Experimental

Trigeminal Pathways Deliver a Low Molecular Weight Drug from the Nose to the Brain and Orofacial Structures

Neil J. Johnson et al.

MOLECULAR PHARMACEUTICS (2010)

Article Chemistry, Multidisciplinary

Intranasal Delivery-Modification of Drug Metabolism and Brain Disposition

Yin Cheong Wong et al.

PHARMACEUTICAL RESEARCH (2010)

Article Pharmacology & Pharmacy

Intranasal nanoemulsion based brain targeting drug delivery system of risperidone

Mukesh Kumar et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)

Article Pharmacology & Pharmacy

Mucoadhesive nanoemulsion-based intranasal drug delivery system of olanzapine for brain targeting

Mukesh Kumar et al.

JOURNAL OF DRUG TARGETING (2008)

Article Pharmacology & Pharmacy

Evaluation of the contribution of the nasal cavity and gastrointestinal tract to drug absorption following nasal application to rats

Tomoyuki Furubayashi et al.

BIOLOGICAL & PHARMACEUTICAL BULLETIN (2007)

Article Pediatrics

Loxapine treatment in an autistic child with aggressive behavior: therapeutic challenges

Shauna P. Reinblatt et al.

JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2006)

Review Pharmacology & Pharmacy

Targeting the dopamine D2 receptor in schizophrenia

Philip Seeman

EXPERT OPINION ON THERAPEUTIC TARGETS (2006)

Review Public, Environmental & Occupational Health

Extrapyramidal symptoms with atypical antipsychotics - Incidence, prevention and management

JM Pierre

DRUG SAFETY (2005)

Article Pharmacology & Pharmacy

Interspecies variability and drug interactions of loxapine metabolism in liver microsomes

SS Bun et al.

EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2003)